Cargando…

Gastric Neuroendocrine Tumors (g-NETs): A Systematic Review of the Management and Outcomes of Type 3 g-NETs

SIMPLE SUMMARY: Gastric well-differentiated neuroendocrine tumors (g-NETs) occur in 5–15% of cases of neuroendocrine neoplasms in the gastrointestinal tract, and they mostly present quite indolent biological behavior. Furthermore, among the g-NETs, the type 3 versions represent the most aggressive s...

Descripción completa

Detalles Bibliográficos
Autores principales:	Laffi, Alice, Lania, Andrea Gerardo Antonio, Ragni, Alberto, Di Vito, Valentina, Liccardi, Alessia, Rubino, Manila, Sesti, Franz, Colao, Annamaria, Faggiano, Antongiulio
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2023
Materias:	Systematic Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10137004/ https://www.ncbi.nlm.nih.gov/pubmed/37190131 http://dx.doi.org/10.3390/cancers15082202

Ejemplares similares

Neoadjuvant Therapy for Neuroendocrine Neoplasms: Recent Progresses and Future Approaches
por: Lania, Andrea, et al.
Publicado: (2021)

What Lies behind Paraneoplastic Hypercalcemia Secondary to Well-Differentiated Neuroendocrine Neoplasms? A Systematic Review of the Literature
por: Giannetta, Elisa, et al.
Publicado: (2022)

Impact of Nutritional Status on Gastroenteropancreatic Neuroendocrine Tumors (GEP-NET) Aggressiveness
por: Barrea, Luigi, et al.
Publicado: (2018)

Case Report: Unmasking Hypercalcemia in Patients With Neuroendocrine Neoplasms. Experience From Six Italian Referral Centers
por: Giannetta, Elisa, et al.
Publicado: (2021)

A Retrospective Analysis of the Correlation between Functional Imaging and Clinical Outcomes in Grade 3 Neuroendocrine Tumors (NETs G3)
por: Laffi, Alice, et al.
Publicado: (2021)

Lipid Metabolism and Homeostasis in Patients with Neuroendocrine Neoplasms: From Risk Factor to Potential Therapeutic Target
por: Modica, Roberta, et al.
Publicado: (2022)

Editorial—Special Issue: Foreword to the Special Issue on NIKE: Neuroendocrine Tumors, Innovation in Knowledge and Education
por: Faggiano, Antongiulio, et al.
Publicado: (2021)

Neuroendocrine Carcinomas with Atypical Proliferation Index and Clinical Behavior: A Systematic Review
por: Feola, Tiziana, et al.
Publicado: (2021)

Somatostatin Analogue Therapy in MEN1-Related Pancreatic Neuroendocrine Tumors from Evidence to Clinical Practice: A Systematic Review
por: La Salvia, Anna, et al.
Publicado: (2021)

Immunotherapy of Neuroendocrine Neoplasms: Any Role for the Chimeric Antigen Receptor T Cells?
por: Fanciulli, Giuseppe, et al.
Publicado: (2022)

Role of FGF System in Neuroendocrine Neoplasms: Potential Therapeutic Applications
por: Vitale, Giovanni, et al.
Publicado: (2021)

Primary Neuroendocrine Neoplasms of the Breast: Still Open Issues
por: Gallo, Marco, et al.
Publicado: (2021)

Neuroendocrine Tumors: A Comprehensive Review on Nutritional Approaches
por: Muscogiuri, Giovanna, et al.
Publicado: (2022)

Vitamin D and Bone Metabolism in Adult Patients with Neurofibromatosis Type 1
por: Modica, Roberta, et al.
Publicado: (2023)

Advances in the Management of Medullary Thyroid Carcinoma: Focus on Peptide Receptor Radionuclide Therapy
por: Grossrubatscher, Erika, et al.
Publicado: (2020)

Emerging Therapies in Pheochromocytoma and Paraganglioma: Immune Checkpoint Inhibitors in the Starting Blocks
por: Fanciulli, Giuseppe, et al.
Publicado: (2020)

Bone Metastases in Neuroendocrine Neoplasms: From Pathogenesis to Clinical Management
por: Altieri, Barbara, et al.
Publicado: (2019)

Gastroenteropancreatic Neuroendocrine Carcinomas: The NET G3 Subcategory Is a Reality
por: Fazio, Nicola, et al.
Publicado: (2017)

Diabetes and Cancer
por: Colao, Annamaria, et al.
Publicado: (2011)

Chronotype: what role in the context of gastroenteropancreatic neuroendocrine tumors?
por: Barrea, Luigi, et al.
Publicado: (2021)

Chemotherapy in Well Differentiated Neuroendocrine Tumors (NET) G1, G2, and G3: A Narrative Review
por: Zappi, Arianna, et al.
Publicado: (2023)

Are Markers of Systemic Inflammatory Response Useful in the Management of Patients With Neuroendocrine Neoplasms?
por: Giannetta, Elisa, et al.
Publicado: (2021)

Cardio-Metabolic Indices and Metabolic Syndrome as Predictors of Clinical Severity of Gastroenteropancreatic Neuroendocrine Tumors
por: Barrea, Luigi, et al.
Publicado: (2021)

Metronomic chemotherapy in patients with advanced neuroendocrine tumors: A single‐center retrospective analysis
por: Arrivi, Giulia, et al.
Publicado: (2022)

Pathology Reporting in Neuroendocrine Neoplasms of the Digestive System: Everything You Always Wanted to Know but Were Too Afraid to Ask
por: Albertelli, Manuela, et al.
Publicado: (2021)

Bone Metabolism and Vitamin D Implication in Gastroenteropancreatic Neuroendocrine Tumors
por: Altieri, Barbara, et al.
Publicado: (2020)

Foreword to the special issue on advances in neuroendocrine neoplasms
por: Vitale, Giovanni, et al.
Publicado: (2021)

Vitamin D and Cancer
por: Vuolo, Laura, et al.
Publicado: (2012)

Grade 3 Neuroendocrine Tumor (G3NET): An Unusual Tumor With A Histochemical Surprise
por: Singhal, Sachi, et al.
Publicado: (2021)

Natural History and Management of Familial Paraganglioma Syndrome Type 1: Long-Term Data from a Large Family
por: Puliani, Giulia, et al.
Publicado: (2020)

Carcinoid Syndrome and Hyperinsulinemic Hypoglycemia Associated with Neuroendocrine Neoplasms: A Critical Review on Clinical and Pharmacological Management
por: Spada, Francesca, et al.
Publicado: (2021)

Diagnosis and Management of Rectal Neuroendocrine Tumors (NETs)
por: Maione, Francesco, et al.
Publicado: (2021)

Laryngeal Neuroendocrine Tumor With Elevated Serum Calcitonin: A Diagnostic and Therapeutic Challenge. Case Report and Review of Literature
por: Feola, Tiziana, et al.
Publicado: (2020)

Laparoscopic and endoscopic cooperative surgery for duodenal neuroendocrine tumor (NET) G1: Report of a case
por: Tsushimi, Takaaki, et al.
Publicado: (2014)

From microbiota toward gastro-enteropancreatic neuroendocrine neoplasms: Are we on the highway to hell?
por: Vitale, Giovanni, et al.
Publicado: (2020)

The Effects of Radioligand Therapy on Quality of Life and Sexual Function in Patients with Neuroendocrine Neoplasms
por: Malandrino, Pasqualino, et al.
Publicado: (2022)

Radiomics in pulmonary neuroendocrine tumours (NETs)
por: Cozzi, Diletta, et al.
Publicado: (2022)

Analysis of Patients with NET G1/G2 Neuroendocrine Tumors of the Small Intestine in the Course of Carcinoid Heart Disease—A Retrospective Study
por: Konsek-Komorowska, Sonia J., et al.
Publicado: (2023)

An Advanced Well-differentiated Pancreatic Neuroendocrine Carcinoma (NET-G3) Associated with Von Hippel-Lindau Disease
por: Miki, Masami, et al.
Publicado: (2018)

The impact of COVID‐19 on the management of neuroendocrine tumors (NETS): An international NET CONNECT survey of NET patients and healthcare professionals treating net patients
por: Cives, Mauro, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_kmbljgeh0esheb17ggaat1j2ra